# Post Market Clinical Follow-Up Registry Study of the aXess Hemodialysis Conduit

Study · id `cardio:ct-nct07925502` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07925502](<https://clinicaltrials.gov/study/NCT07925502>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07925502

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 350 participants.

## Technical summary

Registry record NCT07925502. Allocation not applicable; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2030-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 350 participants (planned count; ClinicalTrials.gov record NCT07925502, source copy `cardio:ctgov-nct07925502-2026-11-13`, retrieved 2026-11-18)
- Planned start: 2026-11 (anticipated) (ClinicalTrials.gov record NCT07925502, source copy `cardio:ctgov-nct07925502-2026-11-13`, retrieved 2026-11-18)
- Primary completion: 2030-12 (anticipated) (ClinicalTrials.gov record NCT07925502, source copy `cardio:ctgov-nct07925502-2026-11-13`, retrieved 2026-11-18)
- Completion: 2033-12 (anticipated) (ClinicalTrials.gov record NCT07925502, source copy `cardio:ctgov-nct07925502-2026-11-13`, retrieved 2026-11-18)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07925502-2026-11-13`, retrieved 2026-11-18)

## The registry's words

- Brief title: Post Market Clinical Follow-Up Registry Study of the aXess Hemodialysis Conduit
- Acronym: aXess4All
- Condition: End Stage Renal Failure, Hemodialysis
- Intervention (Device): Xeltis aXess Hemodialysis Conduit
- Lead sponsor: Xeltis
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Xeltis (`cardio:org-xeltis`)

## Provenance

Content hash: a15cbc5d55396379a182ad0a821007e7dcd83a078a6b173fa852c5c6a4d0effe
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
